Medical Condition News

RSS

MMJ Labs to launch new wearable pain therapy device at runDisney Health and Fitness Expo

MMJ Labs, LLC, industry leaders in non-invasive pain relief, will debut their newest product, VibraCool® Massaging Ice Therapy, at the runDisney Health and Fitness Expo in Orlando, FL.

26 Dec 2016

Saint Louis University geriatrician urges older patients to talk to doctors about too many pills

If you're 65 or older and taking more than four medications, resolve to talk to your doctor about doing a New Year's triage to make sure too many pills aren't making you sick, advises Milta Little, D.O., associate professor of geriatrics at Saint Louis University.

26 Dec 2016

Researchers develop synthetic cardiac stem cells that offer therapeutic benefits

Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell.

26 Dec 2016

Gulf Breeze Recovery underscores importance of high-quality programs for treating opioid addiction

As opioid addiction hits record highs, Gulf Breeze Recovery, a Florida-based addiction recovery center, stresses the importance of high-quality, successful programs for treating addiction.

26 Dec 2016

Four-year Johns Hopkins program provides efficient, less expensive care for patients in East Baltimore

When people with chronic health problems couldn't get around town to their doctors' appointments, a four-year Johns Hopkins program brought the appointments to them.

25 Dec 2016

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company announced today that it has received Health Canada approval for the TRAB 360 Trabeculotomy System.

23 Dec 2016

OTC medical device receives CE Mark approval to treat pain linked to fibromyalgia

AVACEN Medical announced its AVACEN 100, Class-IIa, OTC medical device has received the CE Mark approval to treat widespread pain associated with fibromyalgia.

23 Dec 2016

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

The International Myeloma Foundation today announced the publication in The Lancet of the results of a randomized, phase III trial, conducted by SWOG, a publicly funded international cancer clinical trials network, and led by IMF chairman of the board Brian G.M. Durie, MD.

23 Dec 2016

DDF launches three grants to fund opportunities for gastric cancer research

Debbie's Dream Foundation: Curing Stomach Cancer, an international non-profit organization that raises awareness and funds for stomach cancer, launched three research grants totaling $300,000 for the 2016-2017 grant cycle.

23 Dec 2016

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.

23 Dec 2016

FDA approves first drug to treat children and adults with spinal muscular atrophy

The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.

23 Dec 2016

Researchers find increase in heart attacks during Christmas holidays

University of Melbourne researchers have found an increase in heart attacks around the festive period may be due to more difficult access to hospitals, combined with stress, an excess of alcohol and a fatty diet.

23 Dec 2016

UCLA-led consortium receives $8.6 million NIH grant to map the heart's nervous system

A consortium directed by UCLA's Dr. Kalyanam Shivkumar has received a three-year, $8.6 million grant from the National Institutes of Health to map the heart's nervous system.

23 Dec 2016

UCLA-led research finds promising results for more personalized head and neck cancer treatment

Researchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation.

23 Dec 2016

FDA approves Dexcom’s G5 Mobile CGM system for diabetes management

Dexcom, Inc., the leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration has approved its G5 Mobile CGM system as the first and only continuous glucose monitoring system that can be used to make daily diabetes treatment decisions without finger pricking.

23 Dec 2016

Medical Condition News

MMJ Labs to launch new wearable pain therapy device at runDisney Health and Fitness Expo

Saint Louis University geriatrician urges older patients to talk to doctors about too many pills

Researchers develop synthetic cardiac stem cells that offer therapeutic benefits

Gulf Breeze Recovery underscores importance of high-quality programs for treating opioid addiction

Four-year Johns Hopkins program provides efficient, less expensive care for patients in East Baltimore

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

OTC medical device receives CE Mark approval to treat pain linked to fibromyalgia

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

DDF launches three grants to fund opportunities for gastric cancer research

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

FDA approves first drug to treat children and adults with spinal muscular atrophy

Researchers find increase in heart attacks during Christmas holidays

UCLA-led consortium receives $8.6 million NIH grant to map the heart's nervous system

UCLA-led research finds promising results for more personalized head and neck cancer treatment

FDA approves Dexcom’s G5 Mobile CGM system for diabetes management

Cycle Pharmaceuticals receives license for IP on PARP inhibitor drugs for treating vascular disease

Cedars-Sinai expert explains how to recognize signs and symptoms of stroke during the holidays

Researchers working to develop pill for inherited bleeding disorders

LifePoint Health earns Chest Pain Center Accreditation for 35 facilities

Study reveals impact of histology on SBRT treatment in early-stage NSCLC patients

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News